Report Categories
View AllRecent Articles
View All
TLSA Tiziana drops 403 following Q1 2025 earnings release reporting zero revenue and negative 011 EPS
RiverNorth RIV Stock This Week Idled 20260420
ISBA Isabella reports far worse than expected Q4 2025 EPS sending shares down 63 percent today
The strategic priorities reflected in Century Comm CCS results Q1 2026 EPS Tops Views
Moderna Inc MRNA Initiates Phase 3 Trial for mRNA H5 Pandemic Influenza Vaccine Expanding Pipeline Upside
What Bragg Gaming BRAG disclosed about liquidity position Q4 2025 Below Expectations
SERV Serve Robotics shares drop 467 percent even as Q4 2025 earnings top analyst expectations
US Federal Reserve Leadership and Policy Independence Update Closure of DOJ Criminal Probe into Jerome Powell
Virco VIRC Q1 loss of 008 misses estimate by 1169 but stock rallies 165 on recovery optimism
Bogota FinCo BSBK Declines 098 Amid Market Weakness 20260519
What OI Glass OIs 519 Decline Means for Investors 20260515
Canadian Nat CNQ Q1 2026 Earnings Surprise EPS 117 Up Significant
Rentokil RTO Slides 199 as Selling Pressure Mounts 20260517
HNNA Q1 2026 Earnings Strong PerShare Results Amid Market Headwinds
Jim Cramer Highlights Shift in Tech Leadership Semiconductors and AI Infrastructure Take Center Stage
Select Group Acquires Three Delta Hotels by Marriott Golf Resorts Bolstering UK Hospitality Platform
The Lucrative and Secretive Business of Orchid Breeding A DecadeLong Investment
GPUS Q3 2025 Earnings Losses Persist as Hyperscale Data Ramps Up Investment
Rapid7 Q1 2026 Earnings EPS Surprise Drives Positive Market Response
Heidmar Maritime Holdings Corp HMR Q1 2026 Earnings Massive EPS Beat of 1076 Surprise
DGICB Q1 2026 Earnings Earnings Miss Estimates as EPS Falls Short of Expectations
Soleno Therapeutics Q1 2026 Earnings EPS Misses Estimates by 1494 Stock Holds Steady
Silicon Valley Acquisition Corp Warrants SVAQW Holds Steady Amid Consolidation
NetScout Systems NTCT Edges Higher as Stock Approaches Key Resistance Level
Ready Capital RC Shows Resilience Bounces from Support Eyes Resistance at 192
OS Therapies OSTX Under Pressure Stock Slips Nearly 5 Amid Renewed Selling